Literature DB >> 29697820

Introduction: Autoinflammatory Syndromes Special Issue-hidden mysteries in the corners of autoinflammation.

Scott W Canna1, Raphaela Goldbach-Mansky2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29697820      PMCID： PMC6281335          DOI： 10.1093/intimm/dxy022

Source DB:  PubMed          Journal:  Int Immunol        ISSN： 0953-8178            Impact factor:   4.823


× No keyword cloud information.
  12 in total

Review 1.  Convergent pathways of the hyperferritinemic syndromes.

Authors:  Grant S Schulert; Scott W Canna
Journal:  Int Immunol       Date:  2018-04-25       Impact factor: 4.823

Review 2.  Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1.

Authors:  Ann Marie Szymanski; Michael J Ombrello
Journal:  Int Immunol       Date:  2018-04-25       Impact factor: 4.823

3.  Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.

Authors:  Eric S Weiss; Charlotte Girard-Guyonvarc'h; Dirk Holzinger; Adriana A de Jesus; Zeshan Tariq; Jennifer Picarsic; Eduardo J Schiffrin; Dirk Foell; Alexei A Grom; Sandra Ammann; Stephan Ehl; Tomoaki Hoshino; Raphaela Goldbach-Mansky; Cem Gabay; Scott W Canna
Journal:  Blood       Date:  2018-01-11       Impact factor: 22.113

Review 4.  Hyperferritinemia and inflammation.

Authors:  Kate F Kernan; Joseph A Carcillo
Journal:  Int Immunol       Date:  2017-11-01       Impact factor: 4.823

Review 5.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 6.  Novel aspects of the assembly and activation of inflammasomes with focus on the NLRC4 inflammasome.

Authors:  William G Fusco; Joseph A Duncan
Journal:  Int Immunol       Date:  2018-04-25       Impact factor: 4.823

Review 7.  A clinical update on inflammasomopathies.

Authors:  Hafize Emine Sönmez; Seza Özen
Journal:  Int Immunol       Date:  2017-11-01       Impact factor: 4.823

8.  Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.

Authors:  Bita Shakoory; Joseph A Carcillo; W Winn Chatham; Richard L Amdur; Huaqing Zhao; Charles A Dinarello; Randall Q Cron; Steven M Opal
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

9.  Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis.

Authors:  Evdoxia Kyriazopoulou; Konstantinos Leventogiannis; Anna Norrby-Teglund; Georgios Dimopoulos; Aikaterini Pantazi; Stylianos E Orfanos; Nikoletta Rovina; Iraklis Tsangaris; Theologia Gkavogianni; Elektra Botsa; Eleftheria Chassiou; Anastasia Kotanidou; Christina Kontouli; Panagiotis Chaloulis; Dimitrios Velissaris; Athina Savva; Jonas-Sundén Cullberg; Karolina Akinosoglou; Charalambos Gogos; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  BMC Med       Date:  2017-09-18       Impact factor: 8.775

Review 10.  Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.

Authors:  Mathieu P Rodero; Yanick J Crow
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.